To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to promulgate rules to update certain regulations relating to human cells, tissues, and cellular and tissue-based products, and for other purposes.

Bill 117 hr 6948, also known as the "Human Cells, Tissues, and Cellular and Tissue-Based Products Regulation Update Act," aims to direct the Secretary of Health and Human Services to update regulations pertaining to human cells, tissues, and cellular and tissue-based products. The bill specifically tasks the Commissioner of Food and Drugs with promulgating rules to modernize and improve existing regulations in this area.

The purpose of this legislation is to ensure that regulations governing the use of human cells, tissues, and cellular and tissue-based products are up-to-date and reflective of current scientific advancements and best practices. By updating these regulations, the bill seeks to enhance the safety, efficacy, and quality of these products, ultimately benefiting patients who rely on them for medical treatment.

In addition to updating regulations, the bill may also include provisions aimed at improving oversight, enforcement, and transparency in the regulation of human cells, tissues, and cellular and tissue-based products. These measures are intended to strengthen the regulatory framework governing these products and ensure that they meet the highest standards of safety and quality. Overall, Bill 117 hr 6948 represents a bipartisan effort to modernize and improve regulations related to human cells, tissues, and cellular and tissue-based products, with the ultimate goal of enhancing patient safety and access to innovative medical treatments.